Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder

Drugs in Context
Molly R Belkin, Thomas L Schwartz

Abstract

Clonidine and guanfacine are alpha-2 receptor agonists that decrease sympathetic outflow from the central nervous system. Posttraumatic stress disorder (PTSD) is an anxiety disorder that is theorized to be related to a hyperactive sympathetic nervous system. Currently, the only US Food and Drug Administration (FDA)-approved medications for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. Sometimes use of the SSRIs may not lead to full remission and symptoms of hyperarousal often persist. This article specifically reviews the literature on alpha-2 receptor agonist use for the treatment of PTSD and concludes that while the evidence base is limited, these agents might be considered useful when SSRIs fail to treat symptoms of agitation and hyperarousal in patients with PTSD.

Citations

Jan 26, 2016·Neurobiology of Learning and Memory·Thomas F GiustinoStephen Maren
May 26, 2016·Experimental Neurology·Rebecca C Hendrickson, Murray A Raskind
Nov 12, 2016·Expert Review of Clinical Pharmacology·Eileen Thomas, Dan J Stein
Dec 1, 2017·The International Journal of Neuropsychopharmacology·Christiane ZieglerKatharina Domschke
Apr 6, 2018·Seminars in Cardiothoracic and Vascular Anesthesia·Habib SrourKevin Hatton
Sep 19, 2017·Nature Neuroscience·Akira UematsuJoshua P Johansen
Oct 12, 2018·Journal of Child and Adolescent Psychopharmacology·Timothy RiceBarbara Coffey
Aug 17, 2018·Endocrine, Metabolic & Immune Disorders Drug Targets·Michele IovinoVincenzo Triggiani
Mar 30, 2018·Frontiers in Behavioral Neuroscience·Thomas F Giustino, Stephen Maren
Jul 28, 2019·Stress : the International Journal on the Biology of Stress·Boyd R RorabaughPhillip R Zoladz
Jul 31, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Lu YeSteven Lippmann
Jun 20, 2020·Journal of Child and Adolescent Psychopharmacology·Jeffrey AndersonBarbara J Coffey
Dec 6, 2019·Pharmacology, Biochemistry, and Behavior·Rochelle N WickramasekaraDeniz Yilmazer-Hanke
Mar 27, 2021·Biological Psychiatry·Sofia Leal SantosChristine A Denny
Apr 3, 2021·Journal of Psychiatric Research·Gregory A BurekSadie E Larsen
Jun 15, 2021·Expert Opinion on Pharmacotherapy·Ansab Akhtar, Sangeeta Pilkhwal Sah
Jun 30, 2021·Cannabis and Cannabinoid Research·Cilla ZhouJonathon C Arnold
May 17, 2021·Journal of Neural Transmission·Federico MucciDonatella Marazziti

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
pharmacotherapy

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.